In people with diabetic kidney disease, is there randomized controlled trial evidence to support the use of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent progression?
Cochrane Clinical Answers · 2013
DOI: 10.1002/cca.100 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Cochrane Clinical Answers, 2013. Verfasst von William Cayley Jr. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Jr, W. C. (2013). In people with diabetic kidney disease, is there randomized controlled trial evidence to support the use of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent progression?. Cochrane Clinical Answers. https://doi.org/10.1002/cca.100
Vancouver
Jr WC. In people with diabetic kidney disease, is there randomized controlled trial evidence to support the use of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent progression?. Cochrane Clinical Answers. 2013. doi:10.1002/cca.100
BibTeX
@article{Jr2013,
author = {Jr, William Cayley},
title = {In people with diabetic kidney disease, is there randomized controlled trial evidence to support the use of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent progression?},
journal = {Cochrane Clinical Answers},
year = {2013},
doi = {10.1002/cca.100}
}
EUVIMED